human | Q5 |
P2287 | CRIStin ID | 18090 |
P2671 | Google Knowledge Graph ID | /g/11h52mgw3j |
P496 | ORCID iD | 0000-0002-6509-6221 |
0000-0003-0919-836X | ||
P214 | VIAF ID | 3112148997637459870001 |
P27 | country of citizenship | Norway | Q20 |
P108 | employer | University of Oslo | Q486156 |
Oslo University Hospital | Q3111191 | ||
P734 | family name | Aukrust | Q4821657 |
Aukrust | Q4821657 | ||
Aukrust | Q4821657 | ||
P735 | given name | Pål | Q15732803 |
Pål | Q15732803 | ||
P463 | member of | Norwegian Academy of Science and Letters | Q1423356 |
P106 | occupation | physician | Q39631 |
professor | Q121594 | ||
researcher | Q1650915 | ||
P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
P21 | sex or gender | male | Q6581097 |
Q40627047 | 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases |
Q44980046 | 8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells |
Q40574864 | A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency |
Q60388177 | A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque Destabilization |
Q40386708 | A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue |
Q49515324 | A Young, Immunocompetent Woman with Small Bowel and Hepatic Mucormycosis Successfully Treated with Aggressive Surgical Debridements and Antifungal Therapy |
Q34426813 | A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells |
Q39837123 | A complex role of activin A in non-alcoholic fatty liver disease |
Q38660995 | A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases |
Q83586244 | A helicopter flight does not induce significant changes in systemic biomarker profiles |
Q93158379 | A man in his forties with increasing shortness of breath |
Q37427214 | A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction |
Q82725257 | A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease |
Q50959517 | A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Reply. |
Q33632677 | A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice |
Q38231108 | A vital role for complement in heart disease |
Q91960551 | ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial |
Q47880025 | Abnormal interleukin-7 function in common variable immunodeficiency |
Q71535844 | Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections |
Q112299064 | Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction |
Q41163325 | Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice |
Q35597343 | Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms |
Q49047720 | Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke |
Q37786647 | Activated platelets and atherosclerosis |
Q42219392 | Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13. |
Q84962514 | Activation of Notch signaling in cardiomyocytes during post-infarction remodeling |
Q77513220 | Activation of leukocytes during the uteroplacental passage in preeclampsia |
Q39763541 | Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis |
Q72222617 | Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation |
Q83207389 | Activin A and cardiovascular disease in type 2 diabetes mellitus |
Q42933454 | Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis |
Q37847440 | Activin A in nonalcoholic fatty liver disease |
Q80152966 | Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor |
Q35797015 | Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation |
Q48500144 | Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock |
Q38956465 | Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells |
Q44399693 | Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART. |
Q77579832 | Adhesion molecules in common variable immunodeficiency (CVID)--a decrease in L-selectin-positive T lymphocytes |
Q39399393 | Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly |
Q90482183 | Adipokines and macrophage markers during pregnancy-Possible role for sCD163 in prediction and progression of gestational diabetes mellitus |
Q85315049 | Adipose tissue distribution in relation to insulin sensitivity and inflammation in Pakistani and Norwegian subjects with type 2 diabetes |
Q77953405 | Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system |
Q90724383 | Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes |
Q44967475 | Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure |
Q47577999 | Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia |
Q36145827 | Agents targeting inflammation in heart failure |
Q41078217 | Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure |
Q40753393 | Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation |
Q39064202 | Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia |
Q57452552 | An association between YKL-40 and type 2 diabetes in psychotic disorders |
Q35064061 | An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) mice |
Q83454471 | Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis--a pilot study |
Q96160627 | Anti-inflammatory effects of non-statin low-density lipoprotein cholesterol-lowering drugs: an unused potential? |
Q36425459 | Anti-inflammatory trials in chronic heart failure. |
Q82891570 | Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions |
Q46513414 | Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways |
Q35756182 | Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus |
Q41643052 | Association between altered brain morphology and elevated peripheral endothelial markers--implications for psychotic disorders |
Q46585343 | Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls |
Q41086656 | Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells |
Q34676160 | Association of ficolin-3 with severity and outcome of chronic heart failure |
Q43251081 | Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly |
Q36001528 | Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study |
Q33788258 | Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis |
Q98206078 | Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders |
Q37332292 | Atherosclerotic plaque stability--what determines the fate of a plaque? |
Q52316983 | Attenuated Notch signaling in schizophrenia and bipolar disorder. |
Q59793870 | Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis |
Q50083483 | Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals |
Q42526688 | Base excision repair activities in organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation |
Q81203602 | Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody |
Q46535201 | Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome |
Q58840336 | Body composition and plasma levels of inflammatory biomarkers in COPD |
Q40924208 | Body mass index influence interferon-beta treatment response in multiple sclerosis |
Q42538647 | Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis |
Q90285273 | C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes |
Q47191457 | C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction |
Q39838882 | C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors? |
Q91151203 | CCL21 and prognosis in acute coronary syndrome |
Q88452447 | CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis |
Q34619812 | CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials |
Q80733397 | CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice |
Q61829028 | CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS |
Q40347984 | CVID and Celiac Disease |
Q40073242 | CXC chemokine ligand 16 is increased in gestational diabetes mellitus and preeclampsia and associated with lipoproteins in gestational diabetes mellitus at 5 years follow-up |
Q73690935 | CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells |
Q73573609 | CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes |
Q44070141 | CXCL16 in HIV infection - a link between inflammation and viral replication |
Q97883180 | Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder |
Q38457532 | Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation |
Q39582594 | Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein |
Q43409399 | Carrier rate of resistant enterococci in a tertiary care hospital in Norway. |
Q92601752 | Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension |
Q80722859 | Changes in the cytokine network and complement parameters during open heart surgery |
Q34674064 | Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma |
Q37231421 | Chemokines and cardiovascular risk |
Q44782672 | Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation |
Q79665134 | Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation |
Q74537830 | Chemokines and leukocyte activation in the fetal circulation during preeclampsia |
Q73738653 | Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection |
Q80265488 | Chemokines in cardiovascular risk prediction |
Q46778209 | Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES. |
Q74263491 | Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets |
Q83466863 | Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle |
Q38723655 | Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses |
Q82261730 | Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10 |
Q63727982 | Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis |
Q99413492 | Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis |
Q39193513 | Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis |
Q43965156 | Churg-Strauss syndrome after treatment with Singulair (montelukast) |
Q91242823 | Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway |
Q38979779 | Circulating annexin A5 predicts mortality in patients with heart failure |
Q40580071 | Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia |
Q54551355 | Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome. |
Q57470009 | Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppression |
Q35026334 | Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin |
Q92530848 | Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T |
Q45756867 | Circulating levels of RANTES in human immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy |
Q60774597 | Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study |
Q83370054 | Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure |
Q53268242 | Circulating nucleosomes in chronic heart failure. |
Q80665048 | Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes |
Q54591387 | Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study. |
Q45906534 | Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction. |
Q100300665 | Commentary: Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy |
Q43540341 | Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis |
Q42255402 | Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. |
Q41226485 | Complement Activation Correlates With Disease Severity and Contributes to Cytokine Responses in Plasmodium falciparum Malaria |
Q51302706 | Complement activation and cytokine and chemokines release during mediastinitis. |
Q40520440 | Complement activation by cholesterol crystals triggers a subsequent cytokine response |
Q40684844 | Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment |
Q92755379 | Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling |
Q73740722 | Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression |
Q41992684 | Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study |
Q42552485 | Correction: Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms |
Q38601679 | Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation |
Q43291657 | Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins |
Q81540101 | Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure |
Q34682109 | Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity |
Q74595368 | Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy |
Q35091837 | Cytokine network in scrub typhus: high levels of interleukin-8 are associated with disease severity and mortality |
Q47787677 | Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP. |
Q46651591 | Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases |
Q48240599 | Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia |
Q24799394 | Cytokines as new treatment targets in chronic heart failure |
Q45101318 | Cytomegalovirus (CMV) pneumonitis in AIDS patients: the result of intensive CMV replication? |
Q44650890 | Cytomegalovirus Infection Induces Production of Human Interleukin-10 in Macrophages |
Q44732899 | Cytomegalovirus disease in the upper gastrointestinal tract. Endoscopic findings |
Q36245157 | Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children |
Q54433529 | De novo 19p13.2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability. |
Q46985729 | Decorin, lumican, and their GAG chain-synthesizing enzymes are regulated in myocardial remodeling and reverse remodeling in the mouse |
Q89937225 | Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells |
Q45751621 | Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy |
Q83864020 | Decreased endomyocardial RANKL expression in transplant coronary artery disease |
Q42277348 | Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress |
Q45397427 | Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy |
Q73486387 | Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses |
Q40224562 | Defective IL-4 signaling in T cells defines severe common variable immunodeficiency |
Q89828447 | Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma |
Q58796581 | Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial |
Q53289085 | Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. |
Q40765491 | Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. |
Q39278842 | Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial |
Q57315838 | Dickkopf-1 Enhances Inflammatory Interaction Between Platelets and Endothelial Cells and Shows Increased Expression in Atherosclerosis |
Q33589324 | Differences in insulin sensitivity, lipid metabolism and inflammation between young adult Pakistani and Norwegian patients with type 2 diabetes: a cross sectional study |
Q43489330 | Different COPD disease characteristics are related to different outcomes in the 6-minute walk test |
Q45753594 | Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls |
Q58715724 | Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis |
Q60198843 | Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D |
Q96829002 | Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure |
Q101121172 | Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension |
Q43613617 | Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosis |
Q44508807 | Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants |
Q63430774 | Down-regulated expression of PPARα target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFα |
Q70489764 | Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency |
Q46247298 | Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins |
Q81730161 | Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure |
Q45760209 | Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients wi |
Q64965929 | Early anti-thrombotic and anti-inflammatory actions of statins and fibrates--time for adjuvant therapy in acute coronary syndromes? |
Q92183782 | Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction |
Q57822696 | Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients |
Q60302334 | Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy—Results of a Randomized, Multicenter Trial |
Q89400922 | Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial |
Q54690438 | Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2. |
Q74598927 | Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure |
Q84586692 | Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes |
Q47369556 | Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability |
Q52042595 | Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. |
Q43601429 | Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects |
Q73250285 | Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure |
Q39374116 | Effect of high-intensity interval training on progression of cardiac allograft vasculopathy |
Q91066288 | Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women |
Q40241842 | Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction |
Q32083263 | Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF). |
Q48523684 | Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery |
Q43542961 | Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients |
Q51738018 | Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. |
Q44209429 | Effect of thalidomide in patients with chronic heart failure |
Q46814878 | Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study |
Q44877647 | Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation |
Q78402091 | Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients |
Q92557923 | Effects of interval training on inflammatory biomarkers in patients with ischemic heart failure |
Q45760117 | Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection |
Q34277511 | Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study |
Q91006551 | Elevated Cholesteryl Ester Transfer Protein Activity Early in Pregnancy Predicts Prediabetes 5 Years Later |
Q74428129 | Elevated circulating levels of C-C chemokines in patients with congestive heart failure |
Q40898750 | Elevated inflammatory markers in preeclamptic pregnancies, but no relation to systemic arterial stiffness |
Q46131579 | Elevated levels of activin A in clinical and experimental pulmonary hypertension |
Q44781958 | Elevated levels of activin A in heart failure: potential role in myocardial remodeling |
Q32025738 | Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events |
Q92995476 | Elevated levels of the secreted wingless agonist R-spondin 3 in preeclamptic pregnancies |
Q99720558 | Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement |
Q45772069 | Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection |
Q73834160 | Elevated plasma levels of reduced homocysteine in common variable immunodeficiency--a marker of enhanced oxidative stress |
Q99708092 | Elevated plasma sTIM-3 levels in severe Covid-19 patients |
Q85374055 | Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis |
Q43895869 | Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events. |
Q72668304 | Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes |
Q47394203 | Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size |
Q44924891 | Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality |
Q33731986 | Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function |
Q43237772 | Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome |
Q91151828 | Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning |
Q40663463 | Endostatin is higher and associated with pulmonary involvement in primary Sjögren's syndrome |
Q40327271 | Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization |
Q45758382 | Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection |
Q40624371 | Enhanced base excision repair capacity in carotid atherosclerosis may protect nuclear DNA but not mitochondrial DNA. |
Q79106754 | Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure |
Q79434482 | Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization |
Q74194624 | Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin |
Q72106184 | Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency |
Q45757567 | Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection |
Q43575647 | Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS). |
Q78108701 | Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes |
Q44377514 | Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy |
Q33383387 | Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency |
Q40368553 | Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis |
Q79292895 | Enhanced platelet activation in hyperhomocysteinemic individuals |
Q73279514 | Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy |
Q46611365 | Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling |
Q35102442 | Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway |
Q30405122 | Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza |
Q53158098 | Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chronic heart failure. |
Q84666354 | Explained variance for blood gases in a population with COPD |
Q52316128 | Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder. |
Q104483762 | Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients |
Q46191844 | Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy |
Q44482796 | Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects |
Q35553707 | Expression of matrix metalloproteinases in patients with Wegener's granulomatosis |
Q40242687 | Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway |
Q45214403 | Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy |
Q34103370 | Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke |
Q83784780 | Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality |
Q51363929 | Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. |
Q43957659 | Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects |
Q44356342 | Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects |
Q84273913 | Galectin-3 in heart failure: high levels are associated with all-cause mortality |
Q34269132 | Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). |
Q51996960 | Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. |
Q41470716 | Genetic variants in the DNA repair gene NEIL3 and the risk of myocardial infarction in a nested case-control study. The HUNT Study |
Q45751244 | Glutathione redox disturbances in human immunodeficiency virus infection: immunologic and therapeutic consequences |
Q36913741 | Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy |
Q100518584 | Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency |
Q93158329 | Haemophagocytic lymphohistiocytosis in COVID-19 cases? |
Q38030553 | Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests |
Q44697082 | Herpes simplex virus infection of the central nervous system |
Q39903365 | High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis |
Q61066379 | High Levels of S100A12 Are Associated With Recent Plaque Symptomatology in Patients With Carotid Atherosclerosis |
Q41137641 | High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection |
Q34637905 | High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders |
Q83749896 | High intensity interval training reduces systemic inflammation in post-PCI patients |
Q46702852 | High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins |
Q59812665 | High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections |
Q40289955 | High physical fitness is associated with reduction in basal- and exercise-induced inflammation |
Q53371250 | High resolution computed tomography and pulmonary function in common variable immunodeficiency. |
Q39765481 | High serum CXCL10 in Rickettsia conorii infection is endothelial cell mediated subsequent to whole blood activation |
Q39567915 | High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients |
Q48540294 | High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis |
Q48288216 | Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors |
Q87422395 | Highly sensitive troponin T in patients with acute ischemic stroke |
Q92504933 | Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes |
Q45382212 | Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication |
Q96821982 | How does COVID-19 affect the brain? |
Q44120998 | Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes |
Q44437789 | Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease |
Q79274591 | Hyperhomocysteinemic Subjects Have Enhanced Expression of Lectin-Like Oxidized LDL Receptor-1 in Mononuclear Cells |
Q44228607 | Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension |
Q95939833 | Høyt serum-ferritin ikke kun uttrykk for leversvikt |
Q39901518 | IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients |
Q61829029 | IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy |
Q58746571 | IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction |
Q41536733 | IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy |
Q41050545 | IRF4 Is a Critical Gene in Retinoic Acid-Mediated Plasma Cell Formation and Is Deregulated in Common Variable Immunodeficiency-Derived B Cells |
Q34498817 | Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors |
Q37700032 | Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes |
Q47118417 | Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients |
Q58123225 | Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment |
Q77828328 | Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients |
Q44416290 | Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells |
Q73513244 | Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure |
Q35097101 | Immunomodulating therapy: new treatment modality in congestive heart failure |
Q44086571 | Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy |
Q54224356 | Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction. |
Q38734509 | Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus |
Q91529047 | Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency |
Q45261251 | Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients |
Q51890558 | Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras. |
Q83854535 | Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects |
Q44448935 | Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I. |
Q53663812 | Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate. |
Q93161214 | Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic Stenosis |
Q110220761 | Increased Interleukin-6 and Macrophage Chemoattractant Protein-1 are associated with Respiratory Failure in COVID-19 |
Q50059271 | Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack |
Q38660961 | Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure |
Q36752011 | Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation |
Q41089756 | Increased Serum Levels of the Notch Ligand DLL1 are Associated with Diastolic Dysfunction, Reduced Exercise Capacity, and Adverse Outcome in Chronic Heart Failure |
Q43116827 | Increased YKL-40 expression in patients with carotid atherosclerosis |
Q54085440 | Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. |
Q84114091 | Increased circulating mitochondrial DNA after myocardial infarction |
Q51425425 | Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus. |
Q77564184 | Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation |
Q42207429 | Increased endothelial and macrophage markers are associated with disease severity and mortality in scrub typhus |
Q80916754 | Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure |
Q38832892 | Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages |
Q46419664 | Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro |
Q80579654 | Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation |
Q44820281 | Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors |
Q35089106 | Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection |
Q80442574 | Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication |
Q40174095 | Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization |
Q74292256 | Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure |
Q46967951 | Increased inflammatory markers in children with familial hypercholesterolaemia |
Q110220757 | Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients |
Q91420650 | Increased interleukin 18 activity in adolescents with early-onset psychosis is associated with cortisol and depressive symptoms |
Q48714746 | Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention |
Q110220758 | Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19 |
Q40352345 | Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects |
Q54378142 | Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells. |
Q73418675 | Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency |
Q34277432 | Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure |
Q28200764 | Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation |
Q42279836 | Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection |
Q40473187 | Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. |
Q57315827 | Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis – Potential role in plaque stabilization |
Q42208018 | Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients |
Q43240307 | Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling |
Q41627009 | Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment |
Q39528611 | Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment |
Q43807633 | Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis |
Q35088628 | Increased severity and mortality in adults co-infected with malaria and HIV in Maputo, Mozambique: a prospective cross-sectional study |
Q34983608 | Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis |
Q28575465 | Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure |
Q42220189 | Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis |
Q91799589 | Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study |
Q35756990 | Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin |
Q44909225 | Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects |
Q81576009 | Inflammation and depression: further studies are needed |
Q37090971 | Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology |
Q36314881 | Inflammation in coronary artery disease: potential role for immunomodulatory therapy |
Q34999439 | Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity |
Q36198484 | Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications |
Q47728205 | Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study |
Q64107051 | Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study |
Q38246972 | Inflammatory cytokines as biomarkers in heart failure |
Q46927699 | Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA. |
Q38018808 | Inflammatory cytokines in heart failure: mediators and markers |
Q40774386 | Inflammatory evidence for the psychosis continuum model |
Q78492761 | Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10 |
Q54786635 | Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis. |
Q91246305 | Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors |
Q91899010 | Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors - ERRATUM |
Q41247232 | Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls |
Q83192731 | Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease |
Q45960720 | Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. |
Q81065355 | Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis |
Q84014888 | Inflammatory response to percutaneous coronary intervention in stable coronary artery disease |
Q44896221 | Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction |
Q43083652 | Inflammatory role of platelets in acute coronary syndromes |
Q46507958 | Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients |
Q32055041 | Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes |
Q73486184 | Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection |
Q28285454 | Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder |
Q46611355 | Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency |
Q97565284 | Interleukin 18 (IL-18) and its binding protein (IL-18BP) are increased in patients with epilepsy suggesting low-grade systemic inflammation |
Q41504728 | Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis |
Q47363732 | Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation |
Q44392834 | Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study |
Q50781571 | Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. |
Q38974452 | Interleukin-10 increases reverse cholesterol transport in macrophages through its bidirectional interaction with liver X receptor α. |
Q50059664 | Interleukin-22 reverses human islet dysfunction and apoptosis triggered by hyperglycemia and LIGHT. |
Q37153680 | Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study |
Q51672778 | Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment. |
Q89367585 | Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction |
Q38183314 | Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure |
Q28195974 | Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets |
Q91979457 | Interruption of the CXCL13/CXCR5 Chemokine Axis Enhances Plasma IgM Levels and Attenuates Atherosclerosis Development |
Q45903214 | Intestinal Kaposi sarcoma in a lung transplant recipient: therapy with mammalian target of rapamycin inhibitor and immunosuppression reduction. |
Q39714745 | Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease |
Q58867594 | Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction |
Q64921564 | Is apoptosis an important pathogenic factor in cardiovascular disease? |
Q35761506 | Krill oil attenuates left ventricular dilatation after myocardial infarction in rats |
Q84445078 | LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia |
Q37242976 | LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro |
Q83883509 | Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation |
Q33886486 | Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload |
Q40231142 | Large Reduction in Adiponectin During Pregnancy Is Associated With Large-for-Gestational-Age Newborns |
Q45079437 | Left atrial myxoma and systemic AL-amyloidosis |
Q92214138 | Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages |
Q37576401 | Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus |
Q38904169 | Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial |
Q40251451 | Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function |
Q64943100 | Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. |
Q64885097 | Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study. |
Q74351635 | Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation |
Q46053350 | Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue |
Q38737583 | Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure |
Q45097812 | Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy |
Q91523388 | Lipoprotein(a) concentration is associated with plasma arachidonic acid in subjects with familial hypercholesterolaemia |
Q73781836 | Lipoteichoic acid is a potent inducer of cytokine production in rat and human Kupffer cells in vitro |
Q40417705 | Liver transplantation in patients with primary antibody deficiency |
Q112725400 | Low CETP activity and unique composition of large VLDL and small HDL in women giving birth to small-for-gestational age infants |
Q92708686 | Low Cellular NAD+ Compromises Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting TLR4 Signal Transduction in Human Monocytes |
Q40634829 | Low Circulating Levels of Mitochondrial and High Levels of Nuclear DNA Predict Mortality in Chronic Heart Failure |
Q49241621 | Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia |
Q42101882 | Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA). |
Q36538797 | Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study |
Q92920677 | Low fibre intake is associated with gut microbiota alterations in chronic heart failure |
Q44914830 | Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy |
Q40778270 | Low levels of short- and medium-chain acylcarnitines in HIV-infected patients |
Q81633506 | Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation |
Q79780562 | Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo |
Q101381774 | Lung CD4+ T cells in patients with lung fibrosis produce pro-fibrotic IL-13 together with IFNγ |
Q47749742 | Lung disease, T-cells and inflammation in common variable immunodeficiency disorders |
Q40670646 | Macrophage migration inhibitory factor, a role in COPD. |
Q93062616 | Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts |
Q79255657 | Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction |
Q43664563 | Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy |
Q44814395 | Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset |
Q38218468 | Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review |
Q85581414 | Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH |
Q40991292 | Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia |
Q37439428 | Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis |
Q35790282 | Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection |
Q35406034 | Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure |
Q60198840 | Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo |
Q81542969 | Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection |
Q74414130 | Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes |
Q40172387 | Monocyte/macrophage and T cell activation markers are not independently associated with MI risk in healthy individuals - results from the HUNT Study |
Q87397471 | Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes |
Q48663980 | Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography and Activin A May Predict Mortality in Patients with Carcinoid Intestinal Disease |
Q30611192 | Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure |
Q73937454 | Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease |
Q73942551 | Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure |
Q100413329 | N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis |
Q40385779 | NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture |
Q36956703 | NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis |
Q92404842 | NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity |
Q90480411 | NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium |
Q40169693 | NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective |
Q104064422 | NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet |
Q90279953 | NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction |
Q48760535 | NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome |
Q41956073 | Natural products can be hazardous to health |
Q41826070 | Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice |
Q52008827 | Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users (IVDUs): a follow-up study. |
Q52061222 | Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users. |
Q43056315 | Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. |
Q45164914 | Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages |
Q83748739 | No inflammatory response related to pulmonary hemodynamics in children with systemic to pulmonary shunts |
Q96220491 | Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform |
Q41632689 | Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial |
Q90628427 | OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation |
Q84132906 | Occupational exposure to bacterial single cell protein induces inflammation in lung and blood |
Q43729212 | Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients |
Q32023336 | Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients |
Q50059262 | Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial |
Q39992061 | Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003. |
Q43246905 | Osteoprotegerin concentrations and prognosis in acute ischaemic stroke |
Q36295418 | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function |
Q24626094 | Osteoprotegerin levels in patients with severe mental disorders |
Q84220523 | Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis |
Q38495982 | Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. |
Q84763540 | Osteoprotegerin: a biomarker with many faces |
Q83070486 | Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients |
Q46224491 | Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia |
Q44108169 | PKAI as a potential target for therapeutic intervention. |
Q40451816 | Palmitate promotes inflammatory responses and cellular senescence in cardiac fibroblasts. |
Q40293658 | Patients with depression display cytokine levels in serum and cerebrospinal fluid similar to patients with diffuse neurological symptoms without a defined diagnosis |
Q44604927 | Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo Dependency of xanthomas/xanthelasms, smoking and gender |
Q45986084 | Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation. |
Q40422962 | Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency |
Q48449397 | Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac resynchronization therapy |
Q56942249 | Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis |
Q48458509 | Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials |
Q90268374 | Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial |
Q44752818 | Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. |
Q43263010 | Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery |
Q30873807 | Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines |
Q60198844 | Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences |
Q38620965 | Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study |
Q74225980 | Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy |
Q83417982 | Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy |
Q33522307 | Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors |
Q40454558 | Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients. |
Q61918731 | Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels |
Q88909991 | Plasma hepcidin is associated with future risk of venous thromboembolism |
Q61066385 | Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity |
Q97518157 | Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism |
Q92819435 | Plasma levels of interleukin 27 in falciparum malaria is increased independently of co-infection with HIV: potential immune-regulatory role during malaria |
Q92905413 | Plasma levels of mannose-binding lectin and future risk of venous thromboembolism |
Q39651215 | Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients |
Q46833415 | Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients |
Q51754844 | Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function. |
Q89795919 | Plasma parasitemia as assessed by quantitative PCR in relation to clinical disease severity in African adults with falciparum malaria with and without HIV co-infection |
Q92471934 | Plasma tumour necrosis factor correlates with mRNA expression of tumour necrosis factor and mitochondrial transcription factors in skeletal muscle in patients with chronic heart failure treated with cardiac resynchronization therapy: potential role |
Q35613674 | Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity |
Q47964957 | Platelet activation in heart transplant recipients |
Q79966465 | Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes |
Q83874889 | Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia |
Q45752941 | Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion |
Q73200629 | Possible role of proinflammatory cytokines in heart allograft coronary artery disease |
Q44984913 | Potential anti-inflammatory role of activin A in acute coronary syndromes |
Q36822365 | Potential mechanisms of benefit with thalidomide in chronic heart failure |
Q36283698 | Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation |
Q81585812 | Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality |
Q58761854 | Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14-16 Weeks' Gestation |
Q48445961 | Predictive value of endostatin in chronic heart failure patients with poor kidney function |
Q34287563 | Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study |
Q60952957 | Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis |
Q91143699 | Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study |
Q90831363 | Profiling of immune-related gene expression in children with familial hypercholesterolaemia |
Q92037295 | Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma |
Q38440524 | Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial |
Q41993082 | Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. |
Q73614958 | Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure |
Q50955029 | Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure. |
Q54093961 | Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy. |
Q30587543 | Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. |
Q45149635 | Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction |
Q47870765 | Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. |
Q43425915 | Psychological difficulties related to human immunodeficiency virus-1 infection in intravenous drug users |
Q81504025 | Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation |
Q39742477 | Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation |
Q79347499 | Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy |
Q43459401 | Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients |
Q43913455 | Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome |
Q44283435 | Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy |
Q68223814 | Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features |
Q91047010 | Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI) |
Q91046189 | Reduced brain-derived neurotrophic factor is associated with childhood trauma experiences and number of depressive episodes in severe mental disorders |
Q98564782 | Reduced levels of circulating adhesion molecules in adolescents with early-onset psychosis |
Q71888432 | Reduced serum level of transforming growth factor-beta in patients with IgA deficiency |
Q40945471 | Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system |
Q55034198 | Relation between food provocation and systemic immune activation in patients with food intolerance. |
Q51767101 | Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). |
Q40401947 | Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever |
Q60198849 | Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo |
Q103829228 | Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results |
Q54135975 | Response to letter from Toldo et al. on "NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective". |
Q85638420 | Retinoic acid improves defective TLR9/RP105-induced immune responses in common variable immunodeficiency-derived B cells |
Q36144849 | Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches |
Q40721694 | Rhabdomyolysis and capillary leak syndrome in a patient treated with topical imiquimod |
Q39741712 | Rickettsia conorii is a potent complement activator in vivo and combined inhibition of complement and CD14 is required for attenuation of the cytokine response ex vivo |
Q60907689 | Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency |
Q35915851 | Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study |
Q92291144 | Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study |
Q36806972 | Role of inflammation in the progression of heart failure |
Q40361562 | Role of interleukin-10 in atherogenesis and plaque stabilization |
Q90664623 | Rosuvastatin alters the genetic composition of the human gut microbiome |
Q55027396 | Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas. |
Q35750462 | Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). |
Q87204316 | Secreted Frizzled-Related Protein 3 (sFRP3) in acute coronary syndromes |
Q42255903 | Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients |
Q36519744 | Secreted Wnt modulators in symptomatic aortic stenosis |
Q91305614 | Selective IgA deficiency in humans is associated with reduced gut microbial diversity |
Q91673125 | Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects |
Q91287941 | Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children |
Q58724610 | Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction |
Q41335176 | Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders |
Q46090548 | Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma |
Q92838091 | Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers |
Q83244387 | Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients |
Q45783344 | Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters |
Q89367588 | Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction |
Q52603943 | Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome. |
Q59275996 | Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris |
Q46798854 | Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus |
Q45752853 | Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis |
Q33791924 | Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics |
Q28261811 | Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor |
Q42249543 | Single-nucleotide polymorphisms in Toll-like receptor (TLR)-2, TLR4 and heat shock protein 70 genes and susceptibility to scrub typhus |
Q61066384 | Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability |
Q47355225 | Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? |
Q45269812 | Soluble CD40 ligand in acute and chronic heart failure |
Q45012612 | Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells |
Q82356384 | Soluble CXCL16 and long-term outcome in acute ischemic stroke |
Q40878000 | Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway |
Q48568857 | Soluble CXCL16 predicts long-term mortality in acute coronary syndromes |
Q88937328 | Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction |
Q91937369 | Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals |
Q48677667 | Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology |
Q41624837 | Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure |
Q89704557 | Soluble T-Cell Immunoglobulin Mucin Domain-3 Is Associated With Hepatitis C Virus Coinfection and Low-Grade Inflammation During Chronic Human Immunodeficiency Virus Infection |
Q38459873 | Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). |
Q60044050 | Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria |
Q81205152 | Soluble toll-like receptor 2 in HIV infection: association with disease progression |
Q40790855 | Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis |
Q28729147 | Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies |
Q43677519 | Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences |
Q74397732 | Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects |
Q42228228 | Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment |
Q104568536 | Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers |
Q37297571 | Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype |
Q45783304 | Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival |
Q34025504 | Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis |
Q35804806 | Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice |
Q43782729 | Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig |
Q47709685 | Systemic and Airway Inflammation After Exposure to Fumes from Military Small Arms |
Q34316549 | Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis |
Q99564634 | Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients |
Q36526913 | Systemic inflammation in heart failure--the whys and wherefores |
Q83161496 | Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 |
Q84323166 | Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study |
Q40561220 | Systemic inflammatory responses in African tick-bite fever |
Q84738653 | Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease |
Q43058570 | Systemic markers of inflammation are associated with cardiac allograft vasculopathy and an increased intimal inflammatory component |
Q79165580 | Systemic markers of inflammation--are they useful predictive tools in coronary artery disease? |
Q90548908 | T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF |
Q81403706 | T cells in coronary artery disease: different effects of different T-cell subsets |
Q94319011 | T8. ATHEROGENIC LIPID RATIOS RELATED TO MYELOPEROXIDASE AND C-REACTIVE PROTEIN LEVELS IN PSYCHOTIC DISORDERS |
Q41991646 | TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency |
Q37997644 | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure |
Q90420993 | Tendering for HIV drugs is not clinically justified |
Q43284720 | Testosterone: a novel therapeutic approach in chronic heart failure? |
Q63430768 | Tetradecylselenoacetic Acid, a PPAR Ligand With Antioxidant, Antiinflammatory, and Hypolipidemic Properties |
Q46955401 | Tetradecylthioacetic acid increases fat metabolism and improves cardiac function in experimental heart failure |
Q82889166 | Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats |
Q40794866 | The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis |
Q41418523 | The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial |
Q51072106 | The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. |
Q40225462 | The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy |
Q86088040 | The Notch ligand Delta-like 1 is elevated and associated with mortality in patients with symptomatic aortic stenosis |
Q40333926 | The alternative complement pathway is dysregulated in patients with chronic heart failure |
Q51678036 | The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects. |
Q46677502 | The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*. |
Q56974209 | The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure |
Q91851603 | The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection |
Q39937519 | The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction |
Q39240586 | The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions |
Q28083548 | The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis |
Q37167783 | The complex role of T-cell-based immunity in atherosclerosis |
Q35084669 | The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets. |
Q60198847 | The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency |
Q31152172 | The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial |
Q45000399 | The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types |
Q40787355 | The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls |
Q34200352 | The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure |
Q34513415 | The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling |
Q45738367 | The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy |
Q34104103 | The peripheral blood mononuclear cell microRNA signature of coronary artery disease |
Q48274713 | The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). |
Q43287747 | The prognostic importance of modifiable risk factors after heart transplantation |
Q53082418 | The relationship between markers of extracellular cardiac matrix turnover: infarct healing and left ventricular remodelling following primary PCI in patients with first-time STEMI. |
Q36558817 | The role of intravenous immunoglobulin in the treatment of chronic heart failure |
Q37000806 | The role of statins in heart failure |
Q73297379 | The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients |
Q40361542 | The tumor necrosis factor superfamily in heart failure |
Q50312267 | The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis |
Q110220756 | The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report |
Q35768272 | Therapeutic potential of anticytokine therapy in congestive heart failure |
Q34731377 | Thioredoxin interacting protein is a potential regulator of glucose and energy homeostasis in endogenous Cushing's syndrome |
Q33604761 | Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice |
Q34050642 | Toll-like receptor 9 mediated responses in cardiac fibroblasts |
Q28541982 | Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension |
Q57750433 | Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients |
Q37799379 | Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature |
Q91025919 | Treatment of sleep apnea in patients with paroxysmal atrial fibrillation: design and rationale of a randomized controlled trial |
Q43238382 | Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome |
Q44827257 | Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy |
Q58123267 | Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy |
Q46467659 | Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer |
Q45752470 | Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure |
Q37805514 | Tumor necrosis factor superfamily molecules in acute coronary syndromes |
Q42922255 | Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis |
Q51492970 | Undiagnosed dysglycaemia and inflammation in cardiovascular disease. |
Q47561608 | Up-regulation of NOTCH4 gene expression in bipolar disorder |
Q43753126 | Up-regulation of myocardial DNA base excision repair activities in experimental heart failure |
Q92229629 | Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy |
Q63352311 | Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition |
Q73072392 | Virological and immunological effects of antioxidant treatment in patients with HIV infection |
Q60302301 | Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus-Results of a Multicenter Trial |
Q84585887 | Visfatin/NAMPT - a hot spot in thrombosis? |
Q37998508 | Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology |
Q31111834 | Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort |
Q41430215 | Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis |
Q40969344 | Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis |
Q35213372 | Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD |
Q33799421 | Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy |
Q40272717 | Wnt5a is elevated in heart failure and affects cardiac fibroblast function |
Q99607093 | YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis |
Q68274442 | [Cytomegalovirus disease in the gastrointestinal tract] |
Q69711893 | [HIV and the central nervous system] |
Q74317378 | [Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin] |
Q79816446 | [Should patients with severe sepsis be treated with activated protein C?] |
Q68274437 | [Symptomatic cytomegalovirus infection in patients with acquired immunodeficiency syndrome] |
Q69950462 | [Viral or bacterial meningitis. Differential diagnostic problems] |
nb | Pål Aukrust | wikipedia |
Search more.